International Assets Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.2K Buy
3,380
+3,365
+22,433% +$58.8K ﹤0.01% 1288
2026
Q1
$282 Hold
15
﹤0.01% 2180
2025
Q4
$330 Buy
+15
New +$271 ﹤0.01% 2129
2024
Q4
Sell
-6,998
Closed -$165 1833
2024
Q3
$165 Buy
6,998
+6,833
+4,141% +$290K ﹤0.01% 1568
2024
Q2
$6.65K Buy
+165
New +$6.88K ﹤0.01% 1779
2023
Q2
Sell
-165
Closed -$6.7K 1003
2023
Q1
$6.7K Buy
+165
New +$6.83K ﹤0.01% 881
2021
Q2
Sell
-30
Closed -$2K 1769
2021
Q1
$2K Buy
30
+15
+100% +$1.39K ﹤0.01% 2045
2020
Q4
$1K Buy
+15
New +$1.55K ﹤0.01% 2035

Other funds holding TNDM

International Assets Investment Management's TNDM Position: Q2 2026 in Review

International Assets Investment Management increased its Tandem Diabetes Care (TNDM) stake by 22,433% in Q2 2026, buying an estimated $58.8K and bringing the position to 3,380 shares worth $53.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

International Assets Investment Management first reported a position in TNDM in Q4 2020 and has held it in 8 quarters since. 78 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • International Assets Investment Management held 3,380 shares of Tandem Diabetes Care worth $53.2K as of Q2 2026.
  • International Assets Investment Management bought 3,365 Tandem Diabetes Care shares in Q2 2026, an estimated $58.8K.
  • Tandem Diabetes Care made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1288 holding.
  • International Assets Investment Management first reported a position in Tandem Diabetes Care in Q4 2020 and has held it in 8 quarters since.
  • 78 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.